Baird Medical Investment Holdings Limited
NASDAQ:BDMDMedical - Devices
-$0.09 today
- Market cap
- $50.65M
- Beta
- -1.23
- P/E (TTM)
- -1.3
- EPS (TTM)
- -$0.94
Volume 0.02M
Average 0.37M
BDMD Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Baird Medical Investment Holdings LimitedNASDAQ: BDMD
Capital Expenditures · Q4 FY2025 · quarter ended Dec 2025
Capital expenditures turns positive
Q4 FY2025 capital expenditures was $2.3K, compared with -$2.37M a year earlier. Over 3 fiscal years it compounded at -80.8% a year.
Context
- Capital expenditures amounted to 0.2% of revenue in FY2025, down 7.5 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (42.32K) USD
- Year-over-year change
- +98.5%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (42.32K) | +98.5% |
| FY2024 | 2024-12-31 | (2.85M) | -8.2% |
| FY2023 | 2023-12-31 | (2.64M) | +55.7% |
| FY2022 | 2022-12-31 | (5.95M) | -329.1% |
| FY2021 | 2021-12-31 | (1.39M) | — |
Capital Expenditures vs competitors
How BDMD compares with its peers on the latest reported figures
- BDMD's FY2025 capital expenditures of $42.32K is the 2nd largest of the 4 companies compared; the peer median is $33K.
- Its year-over-year change of -98.5% is the lowest of 4, against a peer median of -65.6%.
- Capital expenditures amounts to 0.2% of revenue for BDMD, versus a peer median of 0.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $411K | -87.6% | -51.5% | 0.4% | |
BDMDBaird Medical Investment Holdings Limited | FY2025 | $42.32K | -98.5% | -80.8% | 0.2% |
OKUROnKure Therapeutics, Inc. | LTM Mar 2026 | $33K | -65.6% | -65.6% | — |
| LTM Mar 2026 | $31K | -16.2% | — | 0.1% | |
| Peer median (excluding BDMD) | $33K | -65.6% | -58.6% | 0.3% | |
Competitors are the stored peer set for BDMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 10.18M | 12.77M | 10.55M | 12.6M | (27.54M) |
| Depreciation & Amortization | 1.4M | 1.47M | 1.38M | 1.51M | 1.1M |
| Deferred Income Tax | (45.38K) | (143.32K) | 0 | 32.77K | (53.5K) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 17.47M |
| Change in Working Capital | (6.57M) | (14.05M) | (14.05M) | (21.7M) | 6.79M |
| Accounts Receivables | (3.49M) | (14.1M) | (9.67M) | (17.8M) | 5.35M |
| Inventory | (2.2M) | 1.57M | 113.66K | (187.54K) | 260.28K |
| Accounts Payables | 274.31K | (100.93K) | 0 | 727.8K | 483.95K |
| Other Working Capital | (1.15M) | (1.41M) | (4.49M) | (4.44M) | 698.51K |
| Other Non-Cash Items | 286.05K | 433.58K | 1.11M | 1.25M | 884.64K |
| Operating Cash Flow | 5.26M | 485.97K | (1.02M) | (6.31M) | (1.34M) |
| Capital Expenditures | (1.39M) | (5.95M) | (2.64M) | (2.85M) | (42.32K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 561 | (12.16K) | 0 | 0 | 0 |
| Investing Cash Flow | (1.39M) | (5.92M) | (2.64M) | (2.85M) | (42.32K) |
| Debt Repayment | (88.58K) | 4.46M | 2.35M | 10.31M | (2.16M) |
| Common Stock Issued | 0 | 0 | 0 | 2.9M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (5.43M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.59M | (46.4K) | 1.11M | (2.49M) | 763.62K |
| Financing Cash Flow | (1.93M) | 4.41M | 3.46M | 10.72M | (1.39M) |
| Effect of Forex Changes | 0 | (297.65K) | (3.11K) | (94.27K) | 375.79K |
| Net Change in Cash | 1.96M | (1.32M) | (200.44K) | 1.46M | (2.4M) |
| Free Cash Flow | 3.87M | (5.47M) | (3.66M) | (9.17M) | (1.39M) |
Baird Medical Investment Holdings Limited
NASDAQ:BDMD
Intrinsic Alpha fair value
Locked
Current Price
$1.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.